| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alive in the burning flames
|
Northshield, Karen
|
|
|
8 |
5 |
p. 452
|
article
|
| 2 |
Antihypertensive drugs and risk of COVID-19?
|
Brown, Joshua D
|
|
|
8 |
5 |
p. e28
|
article
|
| 3 |
Antihypertensive drugs and risk of COVID-19?
|
Tignanelli, Christopher J
|
|
|
8 |
5 |
p. e30-e31
|
article
|
| 4 |
Antihypertensive drugs and risk of COVID-19?
|
Lo, Kevin Bryan
|
|
|
8 |
5 |
p. e29
|
article
|
| 5 |
Antihypertensive drugs and risk of COVID-19? – Authors' reply
|
Fang, Lei
|
|
|
8 |
5 |
p. e32-e33
|
article
|
| 6 |
Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice
|
Beasley, Richard
|
|
|
8 |
5 |
p. 425-427
|
article
|
| 7 |
Armenia: a cultural shift to recognise the respiratory medicine specialty
|
Burki, Talha Khan
|
|
|
8 |
5 |
p. 444-445
|
article
|
| 8 |
Asthma genetics revisited: understanding disease mechanisms by studying ethnically diverse groups
|
Melén, Erik
|
|
|
8 |
5 |
p. 427-429
|
article
|
| 9 |
Azithromycin for primary ciliary dyskinesia: a milestone
|
Poeta, Marco
|
|
|
8 |
5 |
p. 429-430
|
article
|
| 10 |
Blood transfusion strategies and ECMO during the COVID-19 pandemic
|
Koeckerling, David
|
|
|
8 |
5 |
p. e40
|
article
|
| 11 |
Blood transfusion strategies and ECMO during the COVID-19 pandemic – Authors' reply
|
Ramanathan, Kollengode
|
|
|
8 |
5 |
p. e41
|
article
|
| 12 |
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
|
Yang, Xiaobo
|
|
|
8 |
5 |
p. 475-481
|
article
|
| 13 |
Correction to Lancet Respir Med 2020; 8: 506–17
|
|
|
|
8 |
5 |
p. e42
|
article
|
| 14 |
Correction to Lancet Respir Med 2019; 7: 313–24
|
|
|
|
8 |
5 |
p. e42
|
article
|
| 15 |
Could host response guide VAP treatment? No answer yet
|
de Roquetaillade, Charles
|
|
|
8 |
5 |
p. e37
|
article
|
| 16 |
Could host response guide VAP treatment? No answer yet – Authors' reply
|
Hellyer, Thomas P
|
|
|
8 |
5 |
p. e38
|
article
|
| 17 |
COVID-19 infection in children
|
Sinha, Ian P
|
|
|
8 |
5 |
p. 446-447
|
article
|
| 18 |
COVID-19 outbreak: less stethoscope, more ultrasound
|
Buonsenso, Danilo
|
|
|
8 |
5 |
p. e27
|
article
|
| 19 |
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
|
Halpin, David M G
|
|
|
8 |
5 |
p. 436-438
|
article
|
| 20 |
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
|
Bernstein, Jonathan A
|
|
|
8 |
5 |
p. 461-474
|
article
|
| 21 |
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
|
Kobbernagel, Helene E
|
|
|
8 |
5 |
p. 493-505
|
article
|
| 22 |
Efforts escalate to protect homeless people from COVID-19 in UK
|
Kirby, Tony
|
|
|
8 |
5 |
p. 447-449
|
article
|
| 23 |
Expression quantitative trait locus fine mapping of the 17q12–21 asthma locus in African American children: a genetic association and gene expression study
|
Ober, Carole
|
|
|
8 |
5 |
p. 482-492
|
article
|
| 24 |
Impact of COVID-19 on people with cystic fibrosis
|
Colombo, Carla
|
|
|
8 |
5 |
p. e35-e36
|
article
|
| 25 |
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
|
Phua, Jason
|
|
|
8 |
5 |
p. 506-517
|
article
|
| 26 |
Kidney transplant programmes during the COVID-19 pandemic
|
Martino, Francesca
|
|
|
8 |
5 |
p. e39
|
article
|
| 27 |
Monitoring the COVID-19 epidemic in the context of widespread local transmission
|
García-Basteiro, Alberto L
|
|
|
8 |
5 |
p. 440-442
|
article
|
| 28 |
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
|
Wells, Athol U
|
|
|
8 |
5 |
p. 453-460
|
article
|
| 29 |
Opt-out organ donation in England
|
Burki, Talha Khan
|
|
|
8 |
5 |
p. 443
|
article
|
| 30 |
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
|
Ramanathan, Kollengode
|
|
|
8 |
5 |
p. 518-526
|
article
|
| 31 |
POCUS in COVID-19: pearls and pitfalls
|
Cheung, Jonathan Chun-Hei
|
|
|
8 |
5 |
p. e34
|
article
|
| 32 |
Progress in the treatment of pulmonary fibrosis
|
Wijsenbeek, Marlies
|
|
|
8 |
5 |
p. 424-425
|
article
|
| 33 |
Rational use of face masks in the COVID-19 pandemic
|
Feng, Shuo
|
|
|
8 |
5 |
p. 434-436
|
article
|
| 34 |
Reflecting on World Asthma Day in the era of COVID-19
|
The Lancet Respiratory Medicine,
|
|
|
8 |
5 |
p. 423
|
article
|
| 35 |
Respiratory disease and Ramadan
|
Khan, M Hashim
|
|
|
8 |
5 |
p. 449-450
|
article
|
| 36 |
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions
|
Chua, Felix
|
|
|
8 |
5 |
p. 438-440
|
article
|
| 37 |
Treatment for severe acute respiratory distress syndrome from COVID-19
|
Matthay, Michael A
|
|
|
8 |
5 |
p. 433-434
|
article
|
| 38 |
UK senior police officer with COVID-19
|
Kirby, Tony
|
|
|
8 |
5 |
p. 451
|
article
|
| 39 |
Understanding pathways to death in patients with COVID-19
|
Vincent, Jean-Louis
|
|
|
8 |
5 |
p. 430-432
|
article
|
Journal description